ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average